Here are four takeaways:
1. Asia is expected to see high market growth because of research and development activities, more government funding and improved healthcare infrastructure.
2. China, India and Japan will experience the most growth in Asia due to growing economies.
3. Costly neurosurgery equipment, strict regulations and unfavorable reimbursements will prove detrimental to the market’s growth.
4. Some key market players include Doman & Shurtleff, Medtronic, B. Braun Melsungen, Stryker, BrainLab, Integra LifeSciences, NeuroVista and Scopis GmbH.
More articles on devices:
How will Stryker’s acquisitions impact the company? 5 key notes
Stryker buys Physio-Control for $1.28B in 3rd February 2016 acquisition: 6 key notes
Medtech sells ROSA system in France: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
